Re. Schmieder et al., ENDOGENOUS ERYTHROPOIETIN CORRELATES WITH BLOOD-PRESSURE IN ESSENTIAL-HYPERTENSION, American journal of kidney diseases, 29(3), 1997, pp. 376-382
Patients on maintenance hemodialysis with a family history of essentia
l hypertension are at higher risk for increased arterial blood pressur
e when treated with erythropoietin than patients without family histor
y. This study was performed to elucidate the role of endogenous erythr
opoietin in essential hypertension. We conducted a study in 42 untreat
ed patients (mean age, 51 +/- 9 years) with essential hypertension Wor
ld Health Organization stages I or II. Ambulatory 24-hour blood pressu
re (Spacelab 90207), cardiac output (2D guided M-mode echocardiography
and CW Doppler sonography), renal hemodynamics (paraaminohippurate an
d inulin clearance), and endogenous erythropoietin (radioimmunoassay)
together with erythrocyte count, hemoglobin, and hematocrit were measu
red in parallel. Mean 24-hour systolic blood pressure was 145 +/- 13 m
m Hg, and mean diastolic blood pressure was 93 +/- 8 mm Hg, The averag
e erythropoietin concentration was 15.3 +/- 3.7 mU/mL and within the n
ormal range. We found that the higher erythropoietin concentrations, t
he more elevated was both 24-hour ambulatory systolic (r = 0.51, P < 0
.005) and diastolic blood pressure (r = 0.49, P < 0.005). Also, the co
ncentration of endogeneous erythropoietin was correlated with total pe
ripheral resistance as noninvasively determined by echocardiographic a
nd Doppler sonographic measurements (r = 0.40, P < 0.02 and r = 0.49,
P < 0.02, respectively), With increasing erythropoietin concentrations
, renal plasma flow and renal blood flow were found to be progressivel
y reduced (r = -0.32, P < 0.05 and r = -0.35, P < 0.05, respectively)
and renal vascular resistance increased (r = 0.41, P < 0.01). Neither
hematocrit nor hemoglobin nor erythrocyte count were related to endoge
nous erythropoietin concentrations, In human essential hypertension, t
he level of arterial blood pressure is related to endogenous erythropo
ietin, which is hemodynamically mediated by an increase of total perip
heral resistance. Because erythropoietin has shown proliferative and v
asoconstricting effects on the endothelium in experimental studies, we
suggest that endogenous erythropoietin might be an aggravating or eve
n a promoting factor in the pathogenesis of essential hypertension. (C
) 1997 by the National Kidney Foundation, Inc.